Microsatellite instability: A review of what the oncologist should know

331Citations
Citations of this article
641Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The patients with high microsatellite instability (MSI-H)/mismatch repair deficient (dMMR) tumors recently have been reported that can benefit from immunotherapy, and MSI can be used as a genetic instability of a tumor detection index. However, many studies have shown that there are many heterogeneous phenomena in patients with MSI tumors in terms of immunotherapy, prognosis and chemotherapy sensitivity. Here we mainly review the research results of MSI detection methods, the mechanisms of MSI occurrence and its relationship with related tumors, aiming to make a brief analysis of the current research status of MSI and provide comparable reference and guidance value for further research in this field.

Cite

CITATION STYLE

APA

Li, K., Luo, H., Huang, L., Luo, H., & Zhu, X. (2020, January 13). Microsatellite instability: A review of what the oncologist should know. Cancer Cell International. BioMed Central Ltd. https://doi.org/10.1186/s12935-019-1091-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free